Genetic Counseling & Testing

Over the past decade, scientists have discovered specific inherited factors, or genes, that can contribute to the development of some forms of breast, ovarian, colorectal, and other types of cancer. Our experts in cancer risk and genetic counseling can provide individuals and families with information on risk factors and potential genetic testing options. A complete personal and family history of cancer will be used to explain how cancer risk can travel within families and identified those who would benefit from genetic testing.

The most common testing for breast and ovarian cancer is the BRCA1 & BRCA2 test. However, there are other genes that may also play a role so through genetic counseling the most appropriate testing option can be determined. According to the National Cancer Institute, “The likelihood that breast and/or ovarian cancer is associated with BRCA1 or BRCA2 is highest in families with a history of multiple cases of breast cancer, cases of both breast and ovarian cancer, one or more family members with two primary cancers (original tumors at different sites), or an Ashkenazi (Eastern European) Jewish background. However, not every woman in such families carries an alteration in BRCA1 or BRCA2, and not every cancer in such families is linked to alterations in these genes.” Most genetic testing is performed from a blood test and will take several weeks to months to receive a result.

To determine if one is a candidate for genetic testing, we ask that patients schedule a consultation. Genetic counseling includes a assessment of individual risk factors and/or history of cancer, family history of cancer, and a comprehensive review of options based on level of cancer risk, as well as an update on federal legislation against genetic discrimination.

For those who meet criteria for genetic testing, blood can be drawn, informed consent signed, and insurance pre-certification (if applicable) will be completed with assistance from the outside laboratory performing the test. Results and follow-up recommendations will be provided to the patient and other medical providers (as indicated by the patient).

Click here for more information on BRCA 1 & 2 testing.